Aska Pharmaceutical Holdings Co. Ltd. (4886)
Market Closed
10 Aug, 06:00
JPX JPX Primary ¥
2,035. 00
+25
+1.2438%
¥
58.35B Market Cap
- P/E Ratio
66% Div Yield
125,800 Volume
- Eps
¥ 2,010
Previous Close Want to track 4886 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
4886 closed yesterday higher at ¥2,035, an increase of 1.2438% from Friday's close, completing a monthly decrease of -10.5495% or -¥240. Over the past 12 months, 4886 stock lost -0.1472%.
4886 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of ¥32.
The last earnings report, released on May 07, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
Aska Pharmaceutical Holdings Co. Ltd. (4886) FAQ
What is the stock price today?
The current price is ¥2,035.00.
On which exchange is it traded?
Aska Pharmaceutical Holdings Co. Ltd. is listed on JPX.
What is its stock symbol?
The ticker symbol is 4886.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 66%.
What is its market cap?
As of today, the market cap is 58.35B.
Has Aska Pharmaceutical Holdings Co. Ltd. ever had a stock split?
No, there has never been a stock split.
Aska Pharmaceutical Holdings Co. Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | - CEO | JPX Exchange | JP3119660003 ISIN |
| Japan Country | 1,632 Employees | 29 Sep 2026 Last Dividend | - Last Split | - IPO Date |
Overview
ASKA Pharmaceutical Holdings Co.,Ltd. is a conglomerate headquartered in Tokyo, Japan, with a rich history dating back to its founding in 1920. The company operates primarily in the pharmaceutical field while also marking its presence in animal health and hormone testing sectors. It aims to contribute to society by providing innovative healthcare solutions and products. With a strong footprint in Japan, ASKA Pharmaceutical Holdings continues to leverage its extensive research and development capabilities to manufacture and market high-quality pharmaceutical and related products.
Products and Services
ASKA Pharmaceutical Holdings Co.,Ltd. is involved in diverse operations spanning several sectors of healthcare and related industries. Their extensive portfolio includes:
- Pharmaceutical Products: The company focuses on the research, development, manufacture, and sale of pharmaceutical products targeting endocrinology, obstetrics and gynecology, and urology. This dedication underscores ASKA's commitment to addressing complex health challenges in these specialized fields.
- Veterinary Medicines: They research, produce, and distribute an array of veterinary medicines and medical devices. This range extends to feed and feed additives, showcasing their commitment to uplifting animal health and agriculture.
- Reagents and Chemicals: ASKA is involved in the trading (importing and exporting) of crucial reagents, agrochemicals, and industrial chemicals. This also includes the provision of hygiene products and food products along with their raw materials, supporting a wide range of industries beyond healthcare.
- Clinical Examination and Biological Testing: The company's involvement in clinical tests and biological assessment activities further strengthens its role within the healthcare sector, providing essential services for diagnostics and research purposes.
- Medical Devices: Apart from pharmaceuticals and veterinary products, ASKA also extends its technological expertise to the development and sale of sophisticated medical devices, aiding in the advancement of medical care and treatments.
Contact Information
Address: 5-1, Shibaura 2-Chome
Phone: 81 3 5484 8845
Website: https://www.aska-pharma-hd.co.jp
